Herman JJ, Radin R, Schneiderman R. Allergic reactions to measles (rubeola) vaccine in patients hypersensitive to egg protein . J Pediatr
1983;102:196-9.Link to Article
ACIP. Immunization of children infected with human T-lymphotropic virus type III/ lymphadenopathy-associated virus . MMWR 1986;35:595-8, 603-6.
ACIP. New recommended schedule for active immunization of normal infants and children . MMWR 1986;35:577-9.
CDC. Measles surveillance report no. 11, 1977-1981. Atlanta, Georgia: US Department of Health and Human Services, Public Health Service, 1982.
CDC. Measles—United States, 1986 . MMWR 1987;36:301-5.
Davis RM, Orenstein WA, Frank JA Jr, et al. Transmission of measles in medical settings . JAMA
1986;255:1295-8.Link to Article
Frank JA, Orenstein WA, Bart KJ, et al. Major impediments to measles elimination . Am J Dis Child 1985;139:881-8.
Halsey NA, Modlin JF, Jabbour JT, Dubey L, Eddins DL, Ludwig DD. Risk factors in subacute sclerosing panencephalitis: a case-control study . Am J Epidemiol 1980;111:415-24.
Hayden GF. Measles vaccine failure: a survey of causes and means of prevention . Clin Pediatr
1979;18:155-67.Link to Article
Hinman AR, Brandling-Bennett AD, Nieburg PI. The opportunity and obligation to eliminate measles from the United States . JAMA
1979;242:1157-62.Link to Article
Hull HF, Montes JM, Hays PC, Lucero RL. Risk factors for measles vaccine failure among immunized students . Pediatrics 1985;76:518-23.
Jespersen CS, Littauer J, Sagild U. Measles as a cause of fetal defects . Acta Paediatr Scand
1977;66:367-72.Link to Article
Krugman S. Further attenuated measles vaccine: characteristics and use . Rev Infect Dis
1983;5:477-81.Link to Article
Landrigan PJ, Witte JJ. Neurologic disorders following live measles-virus vaccination . JAMA
1973;223:1459-62.Link to Article
Linnemann CC Jr, Dine MS, Roselle GA, Askey PA. Measles immunity after revaccination: results in children vaccinated before 10 months of age . Pediatrics 1982;69:332-5.
Marks JS, Halpin TJ, Orenstein WA. Measles vaccine efficacy in children previously vaccinated at 12 months of age . Pediatrics 1978;62:955-60.
McAleer WJ, Markus HZ, McLean AA, Buynak EB, Hilleman MR. Stability on storage at various temperatures of live measles, mumps and rubella virus vaccines in a new stabilizer . J Biol Stand
1980;8:281-7.Link to Article
Modlin JF, Jabbour JT, Witte JJ, Halsey NA. Epidemiologic studies of measles, measles vaccine, and subacute sclerosing panencephalitis . Pediatrics 1977;59:505-12.
Murphy DM, Brunell PA, Lievens AW, Sheheb ZM. Effect of early immunization on antibody response to reimmunization with measles vaccine as demonstrated by enzyme-linked immunosorbent assay (ELISA) . Pediatrics 1984;74:90-3.
Orenstein WA, Markowitz LE, Preblud SR, Hinman AR, Tomasi A, Bart KJ. Appropriate age for measles vaccination in the United States . Dev Biol Stand 1986;65:13-21.
Siegel M, Fuerst HT. Low birth weight and maternal virus diseases: a prospective study of rubella, measles, mumps, chickenpox, and hepatitis . JAMA
1966;197:680-4.Link to Article
Stetler HC, Orenstein WA, Bernier RH, et al. Impact of revaccinating children who initially received measles vaccine before 10 months of age . Pediatrics 1986;77:471-6.
Weibel RE, Buynak EB, McLean AA, Hilleman MR. Follow-up surveillance for antibody in human subjects following live attenuated measles, mumps, and rubella virus vaccines . Proc Soc Exp Biol Med
1979;162:328-32.Link to Article
Official name: measles virus vaccine, live attenuated.